IFN-α supports proliferation of T cells, and co-administration of IFN-α with CD19-CAR T cells has shown enhanced activity in vitro for treatment of B cell lymphoma (129). The gene discussed is CD19; the disease is B-cell non-Hodgkin lymphoma.